Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Meng M-B et al. – In a comparison of traditional Chinese medicine (TCM) plus transcatheter arterial chemoembolization (TACE) vs TACE alone (therapy I vs II), therapy I benefited pts with unresectable hepatocellular carcinoma (UHCC). Pts with TACE frequency <3 times (subgroup A,) had improved pt survival of patients more symptom amelioration.

Methods

Results


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address